Monday , December 11 2017
Home / Letter From The Editor / GLP-1 Issue #3 Editor’s Note

GLP-1 Issue #3 Editor’s Note

This week we have the results from our GLP-1 Survey. Thanks to the great number of you who participated, and congratulations to Dr. Donald W., of Southern Pines, North Carolina, the winner of our Kindle/Nook giveaway.

As we put together the original survey, our first thoughts were to find out what you wanted to know about GLP-1 analogs, and what your impressions of this class of drugs are. Click here to find out what your colleagues had to say.

Many of you have your own opinions on GLP-1 analogs. We thought you might like to hear how Dr. Aaron Vinik, Director, EVMS Strelitz Diabetes Research Center, uses GLP-1 analogs in his practice, and why and how he selects the patients for GLP-1 analog therapy.

And after you have read the first two features, be sure to review the case of A Caucasian Man with Newly Diagnosed Type 2 Diabetes and Renal Insufficiency, Part 1.